Top 10 Companies in Diabetes Care Devices Market

Diabetes Care Devices Market

Self-management of diabetes is important in patients to reduce mortality risk, prevent long-term complications, and reduce healthcare costs. Diabetes care devices play a critical role in the self-management of diabetes. The glucose monitoring devices (GMD) help keep track of the blood glucose levels, and insulin delivery devices help administrate insulin dosages accordingly. Innovations in these devices make it easy and reliable for diabetic patients to manage diabetes without much effort. Devices like continuous glucose monitoring devices (CGMD) are integrated with insulin pumps equipped with automated algorithms and IQ-based technologies, leading to the measurement of blood glucose levels and administration of insulin in accordance with the glucose levels automatically.

With recent developments in continuous glucose monitoring (CGM) and computer algorithms, closed-loop delivery systems or artificial pancreas (AP) development has gained traction. The AP connects three devices:

  • A blood glucose (BG) sensor that transmits data to a computer algorithm
  • A control algorithm that analyses the data and calculates the appropriate insulin dose
  • An insulin infusion pump that delivers insulin according to the computer’s instructions

Hybrid closed-loop systems are gaining popularity because they combine algorithm-driven automatic insulin delivery with manual mealtime medications.

Thus, the advancements in diabetes care devices, rise in obesity rate, unhealthy lifestyle, and the prevalence of diabetes are expected to drive the global diabetes care devices market  

The Diabetes Care Devices Market is expected to grow at a CAGR of 6.7% from 2021 to reach $31.9 billion by 2028.

Here are the leading 10 companies operating in Diabetes Care Devices Market-

Novo Nordisk A/S

Novo Nordisk A/S was founded in 1923 with its headquarter in Bagsvaerd, Denmark. The company operates in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. The company operates in two segments, Diabetes and Obesity Care, and Biopharmaceuticals. The Diabetes and Obesity Care segment provides insulins, GLP-1 analog, and oral anti-diabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles.

The company sales & markets its products & services in more than 170 countries with strong geographical presence across North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Ypsomed AG

ypsomedYpsomed AG was founded in 1984 and is headquartered in Switzerland. The company operates through three business segments namely Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others segments. The Ypsomed Diabetes Care segment sells and trades insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics.

The company has its geographical presence in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, with its subsidiaries namely Ypsomed Distribution AG, DiaExpert GmbH, Florian Müller GmbH, Ypsomed, and Ypsotec Ag.

Abbott Laboratories

abbottAbbott Laboratories (Abbott) founded in 1888 and is headquartered at Illinois, U.S. The company operates into the manufacturing & sales of health care products worldwide. The company operates through four business segments i.e. nutritionals, pharmaceuticals, diagnostics, vascular, and others. The diabetes care products are offered through its diagnostics segment. The company offers blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes.

The company has its geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa, with more than 28 subsidiaries worldwide including Abbott Diabetes Care, Inc., and Abbott Molecular Inc.

Ascensia Diabetes Care Holdings AG

Ascensia Diabetes Care Holdings AG is established in 2016 through the acquisition of Bayer Diabetes Care by Panasonic Healthcare Holdings. Headquartered in Switzerland, the company operates as a subsidiary of Panasonic Healthcare Holdings and is engaged in providing blood glucose monitoring systems, lancing devices, and diabetes management software.

The company has its geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Hoffmann-La Roche Ltd.

Hoffmann-La Roche Ltd. founded in 1896 is headquartered in Basel, Switzerland. Hoffmann-La Roche Ltd. operates through two divisions i.e. Pharmaceuticals and Diagnostics. The pharmaceuticals division comprises the two business segments Roche pharmaceuticals and chugai. The diagnostics division consists of the four business areas i.e. diabetes care, molecular diagnostics, professional diagnostics and tissue diagnostics. The company’s diabetes care division provides home blood glucose monitoring products and point-of-care testing devices for in-vitro diagnosis.

The company has its geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

A report into the projected growth of the current diabetes care devices market by Meticulous Research® has produced some incredible forecasts for the industry. By 2028, it’s expected to have grown at a CAGR of 6.7%, reaching over $31.9 billion.

Johnson & Johnson

johnson & johnsonJohnson & Johnson was founded in 1887 and is headquartered in New Jersey; U.S. Johnson & Johnson is engaged in developing and marketing of healthcare products globally. Johnson & Johnson operates in three business segments: consumer, pharmaceuticals, and medical devices and diagnostics. The company offers self-monitoring blood glucose meters and insulin delivery devices through its medical devices and diagnostics segment.

The company has strong geographic presence across North America, Europe, Asia-Pacific, Latin America and Middle East & Africa and markets and sales its products in these geographies through more than 230 operating companies located in 60 countries. Johnson & Johnson operates into the diabetes Care market specifically through LifeScan, Inc., Animas Corporation, and Calibra Medical, Inc.

Medtronic PLC

Medtronic PLCMedtronic was founded in 1949 and is headquartered in Dublin, Ireland. The company operates in four business segments i.e. Cardiac And Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Diabetes Group consists of three divisions (Intensive Insulin Management, Non-Intensive Diabetes Therapies, and Diabetes Services & Solutions) that develop, manufacture, and market advanced, integrated diabetes management solutions including insulin pump therapy, continuous glucose monitoring (CGM) systems, and therapy management software.

The company has its geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The company operates through more than 30 subsidiaries including Covidien Ltd., Medtronic Limited, and Medtronic CoreValve LLC.

Becton, Dickinson and Company

1. Becton, Dickinson and Company (U.S.)Becton, Dickinson and Company was founded in 1897 and is headquartered in New Jersey, U.S. The company operates in two business segments i.e. BD Medical and BD Life Sciences. BD medical operates in four segments i.e. Diabetes Care, Medication and Procedural Solutions, Medication Management Solutions, and Pharmaceutical Systems. The diabetes care segment offers syringes, pen needles, used in the treatment of diabetes.

The company markets & sales its products internationally through independent distribution channels across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa, and has more than 30 subsidiaries including GeneOhm Sciences Canada Inc., Becton Dickinson Medical Products Pte. Ltd., Becton Dickinson GmbH, and Becton Dickinson France SAS.

Terumo Corporation

Terumo Corporation founded in 1921, is headquartered in Tokyo, Japan. The company manufactures and sells medical devices and pharmaceuticals worldwide. It also provides diabetes management devices, measuring device systems such as blood glucose and blood pressure monitors; thermometers; pulse oximeters; and walking intensity and body composition monitors.

The company has its geographical presence in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Sanofi

Sanofi was founded in 1973 and is headquartered in Paris, France. The company operates in two segments, Pharmaceuticals and Vaccines. The pharmaceutical segment offers diabetic devices such as SoloSTAR, ClikSTAR, JuniorSTAR, MyStar Extra meter, MyStar Connect to treat diabetes. Additionally, it offers consumer health care products and generic medicines; and pediatric, influenza, adult and adolescent booster, meningitis, and travel and endemic vaccines.

The company manufactures and sells its products in more than 170 countries across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on industry here with Free Sample Report PDF 

Authoritative Research on the Diabetes Care Devices Market

Need more information? Meticulous Research’s new report covers each of these companies in much more detail, providing analysis on the following:

  • Recent financial performance
  • Key products
  • Significant company strategies
  • Partnerships and acquisitions
  • Impact of Covid 19

Comprehensive report provides in global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.

Please download report and learn more:

Leave a Reply

Your email address will not be published. Required fields are marked *